Current Understanding of Vitamin D Metabolism, Nutritional Status, and Role in Disease Prevention11FDA Disclaimer

Nutrition in the Prevention and Treatment of Disease

Volumn , Issue , 2013, Pages 811-837

  Whiting, Susan J ^a   Calvo, Mona S ^b  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

^b CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84885152512     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-391884-0.00043-3     Document Type: Chapter

References (112)

1. National Research Council Recommended Dietary Allowances 1989, National Academy Press, Washington, DC. 10th ed.
2. Calvo M.S., Whiting S.J. Prevalence of vitamin D insufficiency in Canada and the United States: importance to health status and efficacy of current food fortification and dietary supplement use. Nutr. Rev. 2003, 61:107-113.
3. Institute of Medicine Dietary Reference Intakes for Calcium, Phosphorus, Magnesium, Vitamin D, and Fluoride. 1997, National Academy Press, Washington, DC.
4. Institute of Medicine Dietary Reference Intakes for Calcium and Vitamin D 2011, National Academies Press, Washington, DC.
5. Holick M.F. Resurrection of vitamin D deficiency and rickets. J. Clin. Invest. 2006, 116:2062-2072.
6. Norman A. Sunlight, season, skin pigment, vitamin D, and 25-hyd[r]xy D: integral components of the vitamin D endocrine system. Am. J. Clin. Nutr. 1998, 67:1108-1110.
7. Holick M.F. Vitamin D deficiency. N. Engl. J Med. 2007, 357(3):266-281.
8. Webb A.R., Engelsen O. Calculated ultraviolet exposure levels for a healthy vitamin D status. Photochem. Photobiol. 2006, 82:1697-1703.
9. Kimlin M.G., Olds W.J., Moore M.R. Location and vitamin D synthesis: is the hypothesis validated by geophysical data?. J. Photochem. Photobiol. 2007, 86:234-239.
10. Lips P. Vitamin D status and nutrition in Europe and Asia. J. Steroid. Biochem. Mol. Biol. 2007, 103:620-625.
11. Babu U.S., Calvo M.S. Modern India and the vitamin D dilemma: evidence for the need of a national food fortification program. Mol. Nutr. Food Res. 2010, 54:1134-1147.
12. Tangpricha V., Koutkia P., Rieke S.M., Chen T.C., Perez A.A., Holick M.F. Fortification of orange juice with vitamin D: a novel approach for enhancing vitamin D nutritional health. Am. J. Clin. Nutr. 2003, 77:1478-1483.
13. 3 and 25-hydroxyvitamin D in humans: an important tool to define adequate nutritional vitamin D status. J. Steroid Biochem. Mol. Biol. 2007, 103:631-634.
14. Lips P. Vitamin D physiology. Prog. Biophys. Mol. Biol. 2006, 92:4-8.
15. 3 and calcium during winter prevents seasonal bone loss: a randomized controlled open-label prospective trial. J. Bone Miner. Res. 2004, 19:1221-1230.
16. Heaney R.P., Davies K.M., Chen T.C., Holick M.F., Barger-Lux M.J. Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol. Am. J. Clin. Nutr. 2003, 77:204-210.
17. 2) as a vitamin supplement. Am. J. Clin. Nutr. 2006, 84:694-697.
18. 3 in humans. J. Clin. Endocrinol. Metab. 2004, 89:5387-5391.
19. 3 in maintaining circulating concentrations of 25-hydroxyvitamin D. J. Clin. Endocrinol. Metab. 2008, 93:677-681.
20. Anderson P.H., O'Loughlin.P.D., May B.K., Morris H.A. Quantification of mRNA for the vitamin D metabolizing enzymes CYP27B1 and CYP24 and vitamin D receptor in kidney using real-time reverse transcriptase-polymerase chain reaction. J. Mol. Endocrinol. 2003, 31:123-132.
21. Dusso A.S., Brown A.J., Slatopolsky E. Vitamin D. Am. J. Physiol. Renal Physiol. 2005, 289:F8-F28.
22. DeLuca H.F. Overview of general physiologic features and functions of vitamin D. Am. J. Clin. Nutr. 2004, 80:1689s-1696s.
23. Akhter S., Kutuzova G.D., Christakos S., Deluca H.F. Calbindin D(9k) is not required for 1,25-dihyroxyvitamin D(3)-mediated Ca(2+) absorption in small intestine. Arch. Biochem. Biophys. 2006, 460:227-232.
24. Heaney R.P. The case for improving vitamin D status. J. Steroid Biochem. Mol. Biol. 2007, 103:635-641.
25. Hewison M. Vitamin D and the immune system. Endocrinol. Metab. Clin. North Am. 2010, 39:365-379.
26. Liu P.T., Stenger S., Huiying L., Wenzel L., Tan B.H., Krutzik S.R., et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 2006, 311:1770-1773.
27. Baeke F., Takiishi T., Korf H., Gysemans C., Mathieu C. Vitamin D: Modulator of the immune system. Curr. Opin. Pharmacol. 2010, 10:482-496.
28. Jones G., Strugnell S.A., Deluca D.F. Current understanding of the molecular actions of vitamin D. Physiol. Rev. 1998, 78:1193-1231.
29. Norman A.W. Minireview: Vitamin D receptor: New assignments for an already busy receptor. Endocrinology 2006, 147:5542-5548.
30. Fleet J.C. Genomic and proteomic approaches for probing the role of vitamin D in health. Am. J. Clin. Nutr. 2004, 80:1730s-1734s.
31. Fleet J.C. Rapid, membrane-initiated actions of 1,25 dihydroxyvitamin D: what are they and what do they mean?. J. Nutr. 2004, 134:3215-3218.
32. 3. Mol. Cell. Endocrinol. 2002, 197:1-13.
33. Zhou C., Assem M., Tay J.C., Watkins P.B., Blumberg B., Schuetz E.G., et al. Steroid and xenobiotic receptor and vitamin D receptor cross-talk mediates CYP24 expression and drug-induced osteomalacia. J. Clin. Invest. 2006, 116:1703-1712.
34. U.S. Department of Agriculture, Agricultural Research Service (2011). "National Nutrient Database." Available at <>, Accessed September 2011. http://www.nal.usda.gov/fnic/foodcomp/search/.
35. 3 content in fish: Is the vitamin D content adequate to satisfy the dietary requirement for vitamin D?. J. Steroid Biochem. Mol. Biol. 2007, 103:642-644.
36. Calvo M.S., Barton C.N., Whiting S.J. Vitamin D fortification in the U.S. and Canada: current status and data needs. Am. J. Clin. Nutr. 2004, 80:1710S-1716S.
37. Fulgoni V.L., Keast D.R., Bailey R.L., Dwyer J. Foods, fortificants, and supplements: where do Americans get their nutrients?. J. Nutr. 2011, 141:1847-1854.
38. 2 from light exposed edible mushrooms is safe, bioavailable and effectively supports bone growth in rats. Osteoporos. Int. 2012, [Epub ahead of print].
39. Calvo M.S., Whiting S.J. Public health strategies to overcome barriers to optimal vitamin D status in populations with special needs. J. Nutr. 2006, 136:135-139.
40. Cannell J., Bischoff-Ferarri H., Garland C., Giovannucci E., Grant W., Hathcock J., et al. Cod liver oil, vitamin A toxicity, frequent respiratory infections and the vitamin D deficiency epidemic [editorial]. Ann. Otol. Rhinol. Laryngol. 2008, 117:864-870.
41. 2. Am. J. Clin. Nutr. 1998, 68:854-858.
42. 3 supplement use on serum 25OHD concentrations in elderly women in summer and winter. Calcif. Tissue Int. 2004, 74:150-156.
43. 2 dose required to rapidly increase 25OHD levels in osteoporotic women. Eur. J. Clin. Nutr. 2006, 60:681-687.
44. Araki T., Holick M.F., Alfonso B.D., Charlap E., Romero C.M., Rizk D., et al. Vitamin D intoxication with severe hypercalcemia due to manufacturing and labeling errors of two dietary supplements made in the United States. J. Clin. Endocrinol. Metab. 2011, 96:3603-3608.
45. Moore C., Murphy M.M., Keast D.R., Hollick M.F. Vitamin D intake in the United States. J. Am. Diet. Assoc. 2004, 104:980-983.
46. Whiting S.J., Calvo M.S. Dietary recommendations for vitamin D: a critical need for functional end points to establish an estimated average requirement. J. Nutr. 2005, 125:304-309.
47. Bailey R.L., Dodd K.W., Goldman J.A., Gahche J.J., Dwyer J.T., Moshfegh A.J., et al. Estimation of total usual calcium and vitamin D intakes in the United States. J. Nutr. 2010, 140:817-822.
48. Nesby-O'Dell S., Scanlon K.S., Cogswell M.E., Gillespie C., Hollis B.W., Looker A.C., et al. Hypovitamininosis D prevalence and determinants among African American and white women of reproductive age: third National Health and Nutrition Examination Survey, 1988-1994. Am. J. Clin. Nutr. 2002, 76:187-192.
49. Zadshir A., Tareen N., Pan D., Norris K., Martins D. The prevalence of hypovitaminosis D among U.S. adults: data from the NHANES III. Ethn. Dis. 2005, 15(Suppl. 5):97-101.
50. 3 among the general adult population and patients with chronic kidney disease. Ethn. Dis. 2005, 15(Suppl. 5):102-106.
51. Hollis B.W. Circulating 25-hydroxyvitamin D levels indicative of vitamin D sufficiency: implications for establishing a new effective dietary intake recommendation for vitamin D. J. Nutr. 2005, 135:317-322.
52. Gilchrest B.A. Sun protection and vitamin D: three dimensions of obfuscation. J. Steroid Biochem. Mol. Biol. 2007, 103:655-663.
53. Holick M.F., Binkley N.C., Bischoff-Ferrari H.A., Gordon C.M., Hanley D.A., Heaney R.P., et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J. Clin. Endocrinol. Metab. 2011, 96:1911-1930.
54. Working Group of the Australian and New Zealand Bone and Mineral Society, Endocrine Society of Australia, Osteoporosis Australia Vitamin D and adult bone health in Australia and New Zealand: a position statement. Med. J. Austr 2005, 182:281-285.
55. Livingston E.H., Lee S. Percentage of burned body surface area determination in obese and nonobese patients. J Surg. Res. 2000, 91:106-110.
56. Fitzpatrick T.B. The validity and practicality of sun-reactive skin types I through VI. Arch. Dermatol. 1988, 124:869-871.
57. Jablonski N.G., Chaplin G. The evolution of human skin coloration. J. Hum. Evol. 2000, 39:57-106.
58. Lucas R., McMichael T., Smith W., Armstrong B. Solar Ultraviolet Radiation: Global Burden of Disease from Solar Ultraviolet Radiation 2006, World Health Organization, Geneva, Environmental Burden of Disease Series No. 13.
59. 3 production. Environ. Health Perspect. 2012, 120:139-143.
60. Arunabh S., Pollack S., Yeh J., Aloia J.F. Body fat content and 25-hydroxyvitamin D levels in healthy women. J. Clin. Endocrinol. Metab. 2003, 88:157-161.
61. Wortsman J., Matsuoka L.Y., Chen T.C., Lu Z., Holick M.F. Decreased bioavailability of vitamin D in obesity. Am. J. Clin. Nutr. 2000, 72:690-693.
62. Looker, A. C., Johnson, C. L., Lacher, D. A., Pfeiffer, C. M., Schleicher, R. L., and Sempos, C. T. (2011). "Vitamin D Status: United States, 2001-2006," NCHS Data Brief No 59.National Center for Health Statistics,Hyattsville, MD. Available at <>, Accessed September 2011. http://www.cdc.gov/nchs/data/databriefs/db59.pdf/.
63. Looker A.C., Dawson-Hughes B., Calvo M.S., Gunter E.W., Sahyoun N.R. Serum 25-hydroxyvitamin D status of adolescents and adults in two seasonal subpopulations from NHANES III. Bone 2002, 30:771-777.
64. Bischoff-Ferrari H.A, Giovannucci E., Willett W.C., Dietrich T., Dawson-Hughes B. Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am. J. Clin. Nutr. 2006, 84:18-28.
65. Hollis B.W., Horst R.L. The assessment of circulating 25(OH)D and 1,25(OH)2D: where are we and where are we going?. J. Steroid Biochem. Mol. Biol. 2007, 103:473-476.
66. Lips P., Duong T., Oleksik A., Black D., Cummings S., Cox D., et al. A global study of vitamin D status and parathyroid function in postmenopausal women with osteoporosis: baseline data from the Multiple Outcomes of Raloxifene Evaluation clinical trial. J. Clin. Endocrinol. Metab. 2001, 86:1212-1221.
67. Pfeifer M., Bergow B., Minne H. Vitamin D and muscle function. Osteoporos. Int. 2002, 13:187-194.
68. Paterson C. Vitamin D deficiency: A diagnosis often missed. Br. J. Hosp. Med. 2011, 72:456-462.
69. Preimel M., von Domarcus C., Klatte T.O., Kessler S., Schlie J., Meir S., et al. Bone mineralization defects and vitamin D deficiency: Histomorphometric analysis of iliac crest bone biopsies and circulating 25-hydroxyvitamin D in 675 patients. J. Bone Miner. Res. 2010, 25:305-312.
70. Herm F.B., Killguss H., Stewart A.G. Osteomalacia in Hazara District, Pakistan. Trop. Doct. 2005, 35:8-10.
71. Holick M.F., Siris E.S., Binkley N., Beard M.K., Khan A., Katzer J.T., et al. Prevalence of vitamin D inadequacy among postmenopausal North American women receiving osteoporosis therapy. J. Clin. Endocrinol. Metab. 2005, 90:3215-3224.
72. Cranney A., Horsley T., O'Donnell S., Weiler H., Puil L., Ooi D., et al. Effectiveness and safety of vitamin D in relation to bone health. Evid. Rep. Technol. Assess. 2007, 1-235.
73. 3-fortified milk reduces bone loss at clinically relevant skeletal sites in older men: a 2-year randomized controlled trial. J. Bone Miner. Res. 2006, 21:397-405.
74. Bischoff-Ferrari H.A., Willett W.C., Wong J.B., Giovannucci E., Dietrich T., Dawson Hughes B. Fracture prevention with vitamin D supplementation: a meta-analyses of randomized controlled trials. J. Am. Med. Assoc. 2005, 293:2257-2264.
75. 3) on the risk of fall and fracture: a meta-analysis. Q. J. Med. 2007, 100:185-192.
76. Holick M. Vitamin D: extraskeletal health. Endocrinol. Metabol. Clin. 2010, 39:381-400.
77. Gorham E.D., Garland C.F., Garland F.C., Grant W.B., Mohr S.B., Lipkin M., et al. Vitamin D and prevention of colorectal cancer. J. Steroid. Biochem. Mol. Biol. 2005, 97:179-194.
78. Mohr S.B., Gorham E.D., Alcaraz J.E., Kane C.J., Macera C.A., Parsons J.K., et al. Serum 25-hydroxyvitamin D and prevention of breast cancer: pooled analysis. Anticancer Res. 2011, 31:2939-2948.
79. Lappe J.M., Travers-Gustafson D., Davies K.M., Recker R.R., Heaney R.P. Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial. Am. J. Clin. Nutr. 2007, 85:1586-1591.
80. Giovannucci E., Liu Y., Willett W. Cancer incidence and mortality and vitamin D in black and white male health professionals. Cancer Epidemiol. Biomarkers Prev. 2006, 15:2467-2472.
81. Grant W.B. A meta-analysis of second cancers after a diagnosis of nonmelanoma skin cancer: additional evidence that solar ultraviolet-B irradiance reduces the risk of internal cancers. J. Steroid Biochem. Mol. Biol. 2007, 103:668-674.
82. Mathieu C., Gysemans C., Giulietti A., Bouillion R. Vitamin D and diabetes. Diabetologia 2005, 48:1247-1257.
83. Pittas A., Lau J., Hu F., Dawson-Hughes B. The role of vitamin D and calcium in type 2 diabetes: a systematic review and meta-analysis. J. Clin. Endocrinol. Metab. 2007, 92:2017-2029.
84. Pittas A.G., Harris S.S., Stark P.C., Dawson-Hughes B. Vitamin D and type 2 diabetes: a systematic review. Eur. J. Clin. Nutr. 2011, 65:1005-1015.
85. Ascherio A., Munger K.L., Simon K.C. Vitamin D and multiple sclerosis. Lancet Neurol. 2010, 9:599-612.
86. Turner M.K., Hooten W.M., Schmidt J.E., Kerkvliet J.L., Townsend C.O., Bruce B.K. Prevalence and clinical correlates of vitamin D inadequacy among patients with chronic pain. Pain Med. 2008, 9:979-984.
87. Goldsmith J.D., Covic A., Fouque D., Locatelli F., Olgaard K., Rodriguez M., et al. Endorsement of the Kidney Disease Improving Global Outcomes (KDIGO) Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Guidelines: a European Renal Best Practice (ERBP) commentary statement. Nephrol. Dial. Transplant. 2010, 25:3823-3831.
88. Gonzales E.A., Sachdeva A., Oliver D.A., Martin K.J. Vitamin D insufficiency and deficiency in chronic kidney disease: a single center observation study. Am. J. Nephrol. 2004, 24:503-510.
89. LaClair R.E., Hellman R.N., Karp S.L., Kraus M., Ofner S., Li Q., et al. Prevalence of calcidiol deficiency in CKD: a cross-sectional study across latitudes in the United States. Am. J. Kidney Dis. 2005, 45:1026-1033.
90. Deville J., Thorp M.L., Tobin L., Gray E., Johnson E.S., Smith D.H. Effect of ergocalciferol supplementation on serum parathyroid hormone and serum 25-hydroxyvitmain D in chronic kidney disease. Nephrology 2006, 11:555-559.
91. Zisman A.L., Hrisrova M., Ho L.T., Sprague S.M. Impact of ergocalciferol treatment of vitamin D deficiency on serum parathyroid hormone concentrations in chronic kidney disease. Nephrology 2007, 27:36-43.
92. Chonchol M., Scragg R. 25-Hydroxyvitamin D, insulin resistance, and kidney function in the Third National Health and Nutrition Examination Survey. Kidney Int 2007, 71:134-139.
93. Holick M.F. Vitamin D for health and in chronic kidney disease. Semin. Dial. 2005, 18:266-275.
94. Pilz S., Tomaschitz A., März W., Drechsler C., Ritz E., Zittermann A., et al. Vitamin D, cardiovascular disease and mortality. Clin. Endocrinol. (Oxford). 2011, 75:575-584.
95. Zittermann A., Schleitoff S.S., Koerfer R. Putting cardiovascular disease and vitamin D insufficiency into perspective. Br. J. Nutr. 2005, 94:483-492.
96. Schleithoff S.S., Zitterman A., Tenderich G., Berthold H.K., Stehle P., Koerfer R. Vitamin D supplementation improves cytokine profiles in patients with congestive heart failure: A double-blind, randomized, placebo-controlled trial. Am. J. Clin. Nutr. 2006, 83:754-759.
97. U.S. Food and Drug Administration, Center for Drug Evaluation and Research. "Drugs." Available at <>, (2011)Accessed September 2011. http://www.fda.gov/cder/index.html/.
98. Sayre R.M., Dowdy J.C., Shepherd J.G. Reintroduction of a classic vitamin D ultraviolet source. J. Steroid Biochem. Mol. Biol. 2007, 103:686-688.
99. Reid I., Avenell A. Evidence-based policy on dietary calcium and vitamin D. J. Bone Miner. Res. 2011, 26:452-454.
100. Heaney R., Holick M. Why the IOM recommendations for vitamin D are deficient. J. Bone Miner. Res. 2011, 26:455-457.
101. Otten J.J., Hellwig J.P., Meyers L.D. Dietary Reference Intakes: the Essential Guide to Nutrient Requirements 2006, National Academies Press, Washington, DC.
102. Vieth R., Bischoff-Ferrari H., Boucher B.J., Dawson-Hughes B., Garland C.F., Heaney R.P., et al. The urgent need to recommend an intake of vitamin D that is effective. Am. J. Clin. Nutr. 2007, 85:649-650.
103. Johnson M.A., Kimlin M.G. Vitamin D, aging, and the 2005 Dietary Guidelines for Americans. Nutr. Rev. 2006, 64:410-421.
104. 3 than younger adults?. Mol. Nutr. Food Res. 2010, 54:1077-1084.
105. Weisberg P., Scanlon K.S., Li R., Cogswell M.E. Nutritional rickets among children in the United States: review of cases reported between 1986 and 2003. Am. J. Clin. Nutr. 2004, 80:1697S-1705S.
106. Carvalho N.F., Kenney R.D., Carrington P.H., Hall D.E. Severe nutritional deficiencies in toddlers resulting from health food milk alternatives. Pediatrics 2001, 107:1-7.
107. Canadian Pediatric Society reaffirmed October 2010.Vitamin D supplementation: Recommendations for Canadian mothers and infants. Paediatr. Child Health ( 2007)12,583-589.
108. 3 supplementation in a cohort of breastfeeding mothers and their infants: a 6-month follow-up pilot study. Breastfeeding Med. 2006, 1:59-70.
109. Hollis B.W., Johnson D., Hulsey T.C., Ebeling M., Wagner C.L. Vitamin D supplementation during pregnancy: Double blind, randomized clinical trial of safety and effectiveness. J. Bone Miner. Res. 2011, 26:2341-2357.
110. Hathcock J.N., Shao A., Vieth R., Heaney R.P. Risk assessment for vitamin D. Am. J. Clin. Nutr. 2007, 85:6-18.
111. Sanders K.M., Stuart A.L., Williamson E.J., Simpson J.A., Kotowicz M.A., Young D., et al. Annual high-dose oral vitamin D and falls and fractures in older women: a randomized controlled trial. J. Am. Med. Assoc. 2010, 303:1815-1822.
112. Dawson-Hughes B., Harris S.S. High-dose vitamin D supplementation: too much of a good thing?. J. Am. Med. Assoc. 2010, 303:1861-1862.